Generic Is good.(LETTERS)

Beginning of article

Byline: THE WASHINGTON TIMES

Peter Ferrara's Aug. 29 Commentary column, "Poor prescriptions for health prospects," has done American consumers a great disservice. He erroneously suggested that generic drugs place consumers at risk and that the Greater Access to Affordable Pharmaceuticals Act (GAAP) alters intellectual property rights and federal approval requirements for generics. The facts prove Mr. Ferrara wrong on both counts.

GAAP, a modest piece of compromise legislation, levels the playing field between powerful brand companies and pro-consumer generic companies by closing the loopholes that some pharmaceutical companies have exploited to prevent …